The 8th annual World Orphan Drug Congress was held in Barcelona on 13-15th of November 2017. SOM Biotech’s CEO, Dr. Raúl Insa, did a “Pitch & Partner” session on Drug Repurposing in CNS Orphan Indications.
The World Orphan Drug Congress is the marketplace for orphan drug professionals looking at the complete value chain of orphan drug development, from clinical development and R&D to corporate development and market access.
Being Europe’s largest Orphan Drug Congress, this event provides a platform to showcase expertise pharma, biotech, payers, regulators and patient advocates.
More information at World Orphan Drug Congress
